Lactobacillus reuteri ATCC PTA 4659
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Lactobacillus reuteri ATCC PTA 4659, covering 2012-03-29 to 2019-01-14. Get the full timeline:
Most recent: Clinical Trial Update: Lactobacillus Reuteri ATCC PTA 4659 in Ulcerative Colitis [Phase 2]